NJBIZ

BD pledges $110M to expand Nebraska syringe manufacturing

Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...
Pharmaceutical Technology on MSN

BD invests $110m to expand US prefillable syringe production

BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the ...
Fierce Pharma

BD budgets $110M to expand Neb. syringe production

The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...
Drug Delivery Business

BD to invest $110M to support prefilled syringe production, pharma supply chain

BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, ...

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million ...
Contract Pharma

BD to Invest $110M to Expand Production of Prefillable Syringes

BD is investing $110 million to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug delivery.
Nasdaq

BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...